23Andme Holding Co. (NQ: ME )
0.8466 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
All News about 23Andme Holding Co.
23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership
November 07, 2023
The Company’s first-of-its-kind health membership combines exome sequencing, blood testing and direct access to clinicians trained in genetics for ongoing disease prevention and early detection
23andMe Launches Health Action Plan to Provide Personalized Recommendations Based on Genetic and Other Health Data
October 31, 2023
23andMe+ members will receive customized action plans, from recommended lifestyle changes to clinician-ordered lab tests through 23andMe
23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK
October 30, 2023
Following their five year discovery collaboration, 23andMe and GSK have extended their collaboration by entering into a new non-exclusive data licensing agreement, enabling GSK to utilize the 23andMe...
23andMe to Report FY2024 Second Quarter Financial Results
October 25, 2023
23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2023 Annual Meeting
September 27, 2023
23andMe to present data on efficacy and safety and dose selection for the ongoing 23ME-00610 Phase 1/2a clinical trial in patients with advanced solid malignancies
23andMe Reports FY2024 First Quarter Financial Results
August 08, 2023
23andMe to Report FY2024 First Quarter Financial Results
July 25, 2023
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
June 21, 2023
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to help determine their genetic likelihood of having one of...